logo
An Inflection Point For U.S. Competitiveness

An Inflection Point For U.S. Competitiveness

Forbes4 hours ago

'Peace through strength in the 21st century can only be achieved by turning bleeding-edge technology into defense capability faster than our potential adversaries. Today, that bleeding-edge technology largely exists in the commercial world and is dual-use. Our national security R&D ecosystem was developed over the last 65 years and includes the best universities, government laboratories, commercial and defense companies, large and small, and now new defense tech founders and capital. Let's get these entities resourced and organized to take advantage of the innovation being produced and build real defense capability to secure our nation for future generations."As the United States rushes toward its 250th birthday, the nation faces a watershed moment. A moment that will determine whether it sustains its hard-fought and hard-won pole position as the world's leading innovation-driven economy and military power; or whether it falters, falling behind others in a rapidly shifting, global race.
Rapid advancements across nearly every technology are emerging and converging at an unprecedented pace. The fundamental question is: does America possess the capacity—and the resolve—to lead and set the global pace in this era of disruptive innovation?
The Great Convergence
"In this era of relentless technological upheaval, the question is no longer whether the United States can innovate — it's whether we can innovate fast enough to stay ahead. The future belongs to those who harness the chaos of convergence, transforming disruptive technologies into strategic advantage. The key is focus, synthesis, and collaboration across our entire ecosystem of academia, industry, and national labs. The clock is ticking while our global competitors are accelerating their pace.'Today's tech-based innovation landscape is a whirlwind. Farmers harness satellites, sensors, and AI to optimize yields; physicians stand on the brink of personalized medicine driven by genomics and machine learning; energy innovators are reimagining the grid with renewables, nuclear, and fusion; urban planners deploy data analytics to improve city life; cybersecurity experts leverage AI to defend against increasingly sophisticated threats; and AI itself is pushing a generational shift toward how the nation conceives of generating and harnessing energy.
This is not incremental progress—it is a collision of technologies rewriting the rules of industry and society. Economist Joseph Schumpeter described this as 'creative destruction,' where innovation displaces old business models to ignite new waves of economic growth. However, the pace of this powerful force is accelerating: in 2023, for example, the turnover rate of firms in the S&P 500 was 31.4 percent—more than eight percentage points above its 10-year rolling average.
The United States is not running this race alone – other nations and regions are on the track and jockeying to overtake the leader. China's aggressive strategies aim to dominate global markets and reshape security paradigms, challenging America's longstanding leadership. President Trump's recent warning to the White House OSTP underscores the urgency: 'Rivals abroad seek to usurp America's position as the world's greatest maker of marvels and producer of knowledge.' The stakes are clear—who leads in AI, quantum, biotech, and frontier tech will shape the future global order.
Critical decisions lie ahead, the answer to which will determine if the United States is ready to rise to the occasion:
The Urgency of Action
'We must meet this moment and work together to reap the benefits of these new technologies. Exercising new models for productive partnerships among all elements of the ecosystem is essential.'In response to mounting global competition and to help address these strategic questions, the Council on Competitiveness' Technology Leadership and Strategy Initiative, now in its 16th year, has issued a comprehensive new blueprint: Compact for America: A Call to Action for a New, Tech-Driven Industrial Base and National Innovation Ecosystem. This bold plan distills insights captured over several years of intense dialogue from some fifty of the nation's top chief technology officers from across sectors. This major report now offers a strategic pathway forward — a blueprint centers on four critical pillars:
The convergence of platform technologies presents a 'perfect storm.' As innovation capacity and capability become increasingly vital to a nation's competitiveness — now on par with military and economic strength — the United States' ability to lead in innovation will determine its place in the global world order. Our leaders must prioritize the path of innovating relentlessly and leading decisively; the alternative is risking falling behind in the shadows of competitors eager to reshape the future in their image.
The TLSI Compact for America is a rallying cry for leaders across sectors to unite behind a shared vision: restore America's innovation capacity and capability, secure its economic prosperity, and safeguard its national security in an increasingly competitive world.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

ABR's Dividend May Be at Risk
ABR's Dividend May Be at Risk

Yahoo

time6 minutes ago

  • Yahoo

ABR's Dividend May Be at Risk

Arbor Realty Trust, Inc. (NYSE:ABR) is one of the Best REIT Dividend Stocks to Buy in 2025. Rows of neatly arranged, multi-family homes, symbolizing the company's large-scale investing opportunities. The mortgage REIT, which focuses on multifamily properties, had been consistently raising its dividend until mid-2023. However, Arbor Realty Trust, Inc. (NYSE:ABR) paused those increases as rising interest rates began to weigh on the multifamily sector and its earnings. When the REIT last raised its dividend in July 2023, its payout ratio was 75% of its distributable earnings. That figure has since jumped to nearly 150%. Earnings continued to weaken into 2025, with the company reporting $0.28 per share in distributable earnings for the first quarter, or $0.31 per share when excluding a $7.1 million loss from the sale of two properties. In response, it reduced its dividend to $0.30 per share. If earnings decline further, another cut may be on the table. That said, the outlook isn't entirely bleak. While Arbor Realty Trust, Inc. (NYSE:ABR) primarily focuses on low-risk multifamily properties, it also generates income from loan origination and servicing fees, single-family rental properties, and commercial real estate. This diversified revenue base can help Arbor maintain steady income across various phases of the economic cycle. ABR supports a dividend yield of 11.49%, as of June 23. While we acknowledge the potential of ABR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None. Se produjo un error al recuperar la información Inicia sesión para acceder a tu portafolio Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información

Innovative Industrial Properties Navigates Headwinds by Leveraging Its Strengths
Innovative Industrial Properties Navigates Headwinds by Leveraging Its Strengths

Yahoo

time6 minutes ago

  • Yahoo

Innovative Industrial Properties Navigates Headwinds by Leveraging Its Strengths

Innovative Industrial Properties, Inc. (NYSE:IIPR) is one of the Best REIT Dividend Stocks to Buy in 2025. Aerial view of a large REIT building complex, its facade reflecting the city skyline. The company focuses on cannabis-related facilities, mainly grow houses, and operates under a net lease model where tenants handle most property expenses. As the cannabis industry shifts from rapid growth to consolidation, some tenants are struggling to pay rent. Despite these challenges, IIPR has managed to navigate the headwinds fairly well. One of Innovative Industrial Properties, Inc. (NYSE:IIPR)'s main strengths is its solid balance sheet, with a low debt ratio of 0.15, well below industry averages. This low leverage gives the company flexibility to expand its portfolio and support its dividend. From 2017 to 2024, its average AFFO payout ratio was around 85%, which is on the higher side for a net lease REIT. A recent lease adjustment with a major tenant is expected to reduce FFO by $0.16 per share, potentially pushing the payout ratio slightly above 90% in 2025. This makes Innovative Industrial Properties, Inc. (NYSE:IIPR)'s strong financial position even more important and helps justify its dividend yield of over 13%. Innovative Industrial Properties, Inc. (NYSE:IIPR) currently offers a quarterly dividend of $1.90 per share and has been growing its payouts for eight consecutive years. While we acknowledge the potential of IIPR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure. None.

Supreme Court says states may bar women on Medicaid from using Planned Parenthood clinics
Supreme Court says states may bar women on Medicaid from using Planned Parenthood clinics

Yahoo

time6 minutes ago

  • Yahoo

Supreme Court says states may bar women on Medicaid from using Planned Parenthood clinics

The Supreme Court ruled Thursday that states may exclude Planned Parenthood clinics from providing medical screenings and other healthcare for women on Medicaid. The court's conservative majority cast aside the longstanding rule that said Medicaid patients may obtain medical care from any qualified provider. In a 6-3 vote, the justices ruled the Medicaid Act does not give patients an "individual right" to the provider of their choice. The dispute turned on abortion, even though federal funds cannot be used to perform the procedure. Medicaid is funded by the federal government and the states. For decades, conservative states have sought to "defund" Planned Parenthood and argued they did not want to subsidize a leading provider of abortions. But until recently, the federal government and most courts had held that Medicaid patients may go to any qualified provider for healthcare. The legal battle hinged on whether the Medicaid Act gave a patients a right that could be protected in court. The answer was no, said Justice Neil M. Gorsuch speaking for the majority. The court's three liberals, all women, dissented. Justice Ketanji Brown Jackson said the decision "will deprive Medicaid recipients in South Carolina of their only meaningful way of enforcing a right that Congress has expressly granted to them. And, more concretely, it will strip those South Carolinians — and countless other Medicaid recipients around the country — of a deeply personal freedom: the ability to decide who treats us at our most vulnerable." Justices Sonia Sotomayor and Elena Kagan agreed. In theory, a Medicaid patient could file a complaint with the Trump administration and tell the Department of Health and Human Services that the state is failing to comply fully with the Medicaid Act. Planned Parenthood clinics provide cancer screenings, birth control, medical screenings, pregnancy testing, contraception and other healthcare services. Congress pays most of the state's costs for Medicaid, and the law says "any individual eligible for medical assistance" may receive care from any provider who is "qualified to perform the service." Last year, the 4th Circuit Court of Appeals rejected South Carolina's contention that it could exclude Planned Parenthood from the Medicaid program. "We reaffirm that a Medicaid beneficiary may ... vindicate her right under the Medicaid Act to freely choose among qualified healthcare providers, of which Planned Parenthood is one," wrote Judge J. Harvie Wilkinson, a prominent conservative and a Reagan appointee. But the court agreed to hear the state's appeal in Medina vs. Planned Parenthood. Lupe Rodríguez, executive director of National Latina Institute for Reproductive Justice, called Thursday's decision "an attack on our healthcare and our freedom to make our own decisions about our bodies and lives. By allowing states to block Medicaid patients from getting care at Planned Parenthood health centers, the Court has chosen politics over people and cruelty over compassion." Sen. Dick Durbin (D-Ill.) said it was "yet another shameful ruling that inserts the government directly between a patient and their doctor — just like Dobbs three years ago and Skrmetti last week. Intimate, personal decisions about health care shouldn't require sign off from extremist politicians." He was referring to the 2022 decision that overturned Roe vs. Wade and last week's ruling upholding state laws that ban hormone treatment for transgender teens. Carol Tobias, president of the National Right to Life Committee, praised the decision as a landmark. "We are grateful the Supreme Court has recognized the right of states to direct taxpayer dollars toward life-affirming healthcare providers,' she said. 'No one should be forced to subsidize the abortion industry with their tax dollars.' After the Supreme Court overturned the constitutional right to abortion, South Carolina made most abortions a crime. But the state continued its legal fight to prevent Medicaid patients from receiving care at Planned Parenthood's clinics in Charleston and Columbia. Gov. Henry McMaster, who issued the ban on Planned Parenthood in 2018, said he did so to protect "his state's sovereign interests." Critics of the move said the state has a severe shortage of doctors and medical personnel who treat low-income patients on Medicaid. Get the L.A. Times Politics newsletter. Deeply reported insights into legislation, politics and policy from Sacramento, Washington and beyond, in your inbox twice per week. This story originally appeared in Los Angeles Times.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store